Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 3159
Gene Symbol: HMGA1
HMGA1 		0.510 Biomarker group MGD
Entrez Id: 2313
Gene Symbol: FLI1
FLI1 		0.100 Biomarker group HPO
Entrez Id: 6778
Gene Symbol: STAT6
STAT6 		0.100 Biomarker group HPO
Entrez Id: 5573
Gene Symbol: PRKAR1A
PRKAR1A 		0.100 Biomarker group HPO
Entrez Id: 6794
Gene Symbol: STK11
STK11 		0.100 Biomarker group HPO
Entrez Id: 6794
Gene Symbol: STK11
STK11 		0.100 CausalMutation group CLINVAR
Entrez Id: 5728
Gene Symbol: PTEN
PTEN 		0.100 Biomarker group HPO
Entrez Id: 64218
Gene Symbol: SEMA4A
SEMA4A 		0.100 Biomarker group HPO
Entrez Id: 4665
Gene Symbol: NAB2
NAB2 		0.100 Biomarker group HPO
Entrez Id: 6224
Gene Symbol: RPS20
RPS20 		0.100 Biomarker group HPO
Entrez Id: 657
Gene Symbol: BMPR1A
BMPR1A 		0.100 Biomarker group HPO
Entrez Id: 2099
Gene Symbol: ESR1
ESR1 		0.010 GeneticVariation group BEFREE There does not appear to be any association between the presence or absence of spliced variants of estrogen receptor and uterine tumor formation at the mRNA level. 8735603 1996
Entrez Id: 1440
Gene Symbol: CSF3
CSF3 		0.300 Therapeutic group CTD_human Phase II trial of paclitaxel in patients with soft-tissue sarcoma. 9774950 1998
Entrez Id: 3757
Gene Symbol: KCNH2
KCNH2 		0.010 Biomarker group LHGDN Selective expression of HERG and Kv2 channels influences proliferation of uterine cancer cells. 15202000 2004
Entrez Id: 2925
Gene Symbol: GRPR
GRPR 		0.010 AlteredExpression group LHGDN Gastrin-releasing peptide receptors in normal and neoplastic human uterus: involvement of multiple tissue compartments. 15941862 2005
Entrez Id: 1027
Gene Symbol: CDKN1B
CDKN1B 		0.300 Biomarker group CTD_human A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression. 16391232 2006
Entrez Id: 3159
Gene Symbol: HMGA1
HMGA1 		0.510 AlteredExpression group BEFREE To determine whether these findings are relevant to human disease, we evaluated primary human uterine neoplasms and found that HMGA1a mRNA and protein levels are increased in most high-grade neoplasms but not in normal uterine tissue, benign tumors, or most low-grade neoplasms. 17483309 2007
Entrez Id: 3845
Gene Symbol: KRAS
KRAS 		0.300 Biomarker group CTD_human K-ras mutations in lung tumors and tumors from other organs are consistent with a common mechanism of ethylene oxide tumorigenesis in the B6C3F1 mouse. 17325976 2007
Entrez Id: 1956
Gene Symbol: EGFR
EGFR 		0.020 AlteredExpression group BEFREE Concomitant erbB-1 and erbB-2 overexpression was detected only in 1 out of 25 (4%) uterine neoplasms. erbB-1 was overexpressed in a sarcoma botryoides of the uterine cervix. 17549377 2007
Entrez Id: 6790
Gene Symbol: AURKA
AURKA 		0.010 GeneticVariation group LHGDN STK15 F31I polymorphism is associated with increased uterine cancer risk: a pilot study. 17599395 2007
Entrez Id: 140690
Gene Symbol: CTCFL
CTCFL 		0.010 AlteredExpression group LHGDN Global expression analysis of cancer/testis genes in uterine cancers reveals a high incidence of BORIS expression. 17363524 2007
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2 		0.010 AlteredExpression group BEFREE Concomitant erbB-1 and erbB-2 overexpression was detected only in 1 out of 25 (4%) uterine neoplasms. erbB-1 was overexpressed in a sarcoma botryoides of the uterine cervix. 17549377 2007
Entrez Id: 3159
Gene Symbol: HMGA1
HMGA1 		0.510 Biomarker group CTD_human Cyclooxygenase inhibitors block uterine tumorigenesis in HMGA1a transgenic mice and human xenografts. 18645019 2008
Entrez Id: 1956
Gene Symbol: EGFR
EGFR 		0.020 Biomarker group LHGDN MMTV-EGF receptor transgene promotes preneoplastic conversion of multiple steroid hormone-responsive tissues. 17960555 2008
Entrez Id: 331
Gene Symbol: XIAP
XIAP 		0.010 Biomarker group LHGDN Akt and XIAP regulate the sensitivity of human uterine cancer cells to cisplatin, doxorubicin and taxol. 18071906 2008